Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.

about

Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.

Item

http://www.wikidata.org/entity/Q47846912

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Predictive and prognostic valu ...... lary carcinoma of the thyroid.

@en

Predictive and prognostic valu ...... lary carcinoma of the thyroid.

@nl

type

Item

label

Predictive and prognostic valu ...... lary carcinoma of the thyroid.

@en

Predictive and prognostic valu ...... lary carcinoma of the thyroid.

@nl

prefLabel

Predictive and prognostic valu ...... lary carcinoma of the thyroid.

@en

Predictive and prognostic valu ...... lary carcinoma of the thyroid.

@nl

P1476

Predictive and prognostic valu ...... llary carcinoma of the thyroid

@en

P2093

Agostino Chiaravalloti

http://www.w3.org/2001/XMLSchema#string

Davide Donner

http://www.w3.org/2001/XMLSchema#string

Giorgio Saladini

http://www.w3.org/2001/XMLSchema#string

Manuela Vadrucci

http://www.w3.org/2001/XMLSchema#string

Orazio Schillaci

http://www.w3.org/2001/XMLSchema#string

Young AIMN Working Group

http://www.w3.org/2001/XMLSchema#string

P2860

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging.

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment.

Medullary thyroid cancer: management guidelines of the American Thyroid Association.

How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals.

Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.

What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?

Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.

Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.

P2888

s12149-017-1213-0

P304

7-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12149-017-1213-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28986764

http://www.w3.org/2001/XMLSchema#string